Your browser doesn't support javascript.
loading
Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice.
van Eenige, Robin; Ying, Zhixiong; Tramper, Naomi; Wiebing, Vera; Siraj, Zohor; de Boer, Jan Freark; Lambooij, Joost M; Guigas, Bruno; Qu, Hongchang; Coskun, Tamer; Boon, Mariëtte R; Rensen, Patrick C N; Kooijman, Sander.
Afiliação
  • van Eenige R; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: r.van_eenige@lumc.nl.
  • Ying Z; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Tramper N; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Wiebing V; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Siraj Z; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • de Boer JF; Departments of Pediatrics and Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Lambooij JM; Department of Parasitology, Leiden University Medical Center, Leiden, the Netherlands; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
  • Guigas B; Department of Parasitology, Leiden University Medical Center, Leiden, the Netherlands.
  • Qu H; Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, United States.
  • Coskun T; Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, United States.
  • Boon MR; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Rensen PCN; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Kooijman S; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: s.kooijman@lumc.nl.
Atherosclerosis ; 372: 19-31, 2023 05.
Article em En | MEDLINE | ID: mdl-37015151
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores dos Hormônios Gastrointestinais / Aterosclerose / Receptor do Peptídeo Semelhante ao Glucagon 1 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores dos Hormônios Gastrointestinais / Aterosclerose / Receptor do Peptídeo Semelhante ao Glucagon 1 Idioma: En Ano de publicação: 2023 Tipo de documento: Article